Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02445781 · ClinicalTrials.gov registry record · Early Phase 1
Differing Levels of Hypoglycemia
A Early Phase 1 study of Hypoglycemia, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 32
- Enrollment target
- 2
- Study locations
NCT02445781: Recruiting Early Phase 1 study of Hypoglycemia, sponsored by University of Maryland, Baltimore.
NCT02445781 is a Early Phase 1 study of Hypoglycemia that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 32 participants, below the 506-participant average among 40 other Hypoglycemia trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02445781, a Early Phase 1 study of Hypoglycemia, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 32 participants
- Enrollment target
- 2
- Study locations
Study Summary
Hypoglycemia can produce a spectrum of pro-inflammatory and pro-atherothrombotic changes. To date no studies appear to have investigated the effects of differing levels of hypoglycemia on the vasculature and pro-atherothrombotic balance during hypoglycemia in healthy man. The specific aim of our study will be to determine the effects of differing levels of hypoglycemia on in-vivo vascular biologic mechanisms in a healthy population.
Primary Outcome
baseline (pre) measurements compared to end of clamp (post) measurements
Conditions Studied
Interventions
- DEVICE Glucose clamp
Study Locations (2)
Maryland
- University of Maryland, Baltimore - Baltimore
- University of Maryland, Baltimore - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-07 |
| Est. Completion | 2026-12 |
| Phase | Early Phase 1 |
What NCT02445781 shows while recruiting
NCT02445781 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 506-participant average among 40 other Hypoglycemia trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Hypoglycemia appearing as the primary indexed condition, and to 1 intervention - of which Glucose clamp is the first listed.
NCT02445781 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT02445781 about?
NCT02445781 is a clinical study titled "Differing Levels of Hypoglycemia". Hypoglycemia can produce a spectrum of pro-inflammatory and pro-atherothrombotic changes. To date no studies appear to have investigated the effects of differing levels of hypoglycemia on the vasculature and pro-atherothrombotic balance during hypoglycemia in healthy man. The specific aim of our stu...
What is the current status of trial NCT02445781?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 32 participants. The study started on 2015-07. Estimated completion is 2026-12.
What conditions does trial NCT02445781 study?
This clinical trial studies the following conditions: Hypoglycemia.
What interventions are being tested in trial NCT02445781?
The interventions under investigation include: Glucose clamp (DEVICE).
Who is sponsoring clinical trial NCT02445781?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02445781 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoglycemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02445781's enrollment target sits among peer trials
32 22nd of 40 higher than 19 of 40 other Hypoglycemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypoglycemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
RECRUITING · Early Phase 1
-
Effect of C-peptide on Hypoglycemic Counterregulation
RECRUITING · Early Phase 1
-
Adrenergic System in Islet Transplantation
ACTIVE NOT RECRUITING · Early Phase 1
-
External Carotid Blood Flow in Individuals With Post-Bariatric Hypoglycemia
RECRUITING
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
Diabetes Clinical Decision Support
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
- NCT03530852 · 32 participants · NA
A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia